A detailed history of Tcg Crossover Management, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 5,319,148 shares of OCUL stock, worth $52 Million. This represents 6.0% of its overall portfolio holdings.

Number of Shares
5,319,148
Previous 5,319,148 -0.0%
Holding current value
$52 Million
Previous $36.4 Million 27.19%
% of portfolio
6.0%
Previous 5.45%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.85 - $10.93 $20.5 Million - $58.1 Million
5,319,148 New
5,319,148 $48.4 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $752M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Tcg Crossover Management, LLC Portfolio

Follow Tcg Crossover Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Crossover Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Crossover Management, LLC with notifications on news.